Plasma Progastrin-Releasing Peptide and Chromogranin A Assays for Diagnosing and Monitoring Lung Well-Differentiated Neuroendocrine Tumors: A Brief Report-Reference-Cited by-同舟云学术

Plasma Progastrin-Releasing Peptide and Chromogranin A Assays for Diagnosing and Monitoring Lung Well-Differentiated Neuroendocrine Tumors: A Brief Report

Published:2023-03 Issue:3 Volume:18 Page:369-376
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Nisman Benjamin,Oleinikov Kira,Nechushtan Hovav,Maimon Ofra,Atlan Karine,Peled Nir,Gross David,Peretz Tamar,Meirovitz Amichay,Grozinsky-Glasberg Simona

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference14 articles.

1. Neuroendocrine tumors of the lung: an update;Rekhtman;Arch Pathol Lab Med,2010

2. The 2021 WHO classification of lung tumors: impact of advances since 2015;Nicholson;J Thorac Oncol,2022

3. Neuroendocrine and adrenal tumors, version 2.2021, NCCN Clinical Practice Guidelines in Oncology;Shah;J Natl Compr Canc Netw,2021

4. An assessment of circulating chromogranin A as a biomarker of bronchopulmonary neuroendocrine neoplasia: a systematic review and meta-analysis;Malczewska;Neuroendocrinology,2020

5. Blood chromogranin A is not effective as a biomarker for diagnosis or management of bronchopulmonary neuroendocrine tumors/neoplasms;Matar;Neuroendocrinology,2020

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progastrin-Releasing Peptide As a Diagnostic Biomarker of Pulmonary and Non-Pulmonary Neuroendocrine Neoplasms;Endocrine Research;2024-07-23

2. Comment on “Plasma Progastrin-Releasing Peptide and Chromogranin A Assays for Diagnosing and Monitoring Lung Well-Differentiated Neuroendocrine Tumors: A Brief Report”;Journal of Thoracic Oncology;2023-11

3. An Overview of Circulating Biomarkers in Neuroendocrine Neoplasms: A Clinical Guide;Diagnostics;2023-08-31

4. Pro-Gastrin-Releasing Peptide as a Biomarker in Lung Neuroendocrine Neoplasm;Cancers;2023-06-22

5. Plasma Biomarkers to Monitor Bronchopulmonary Carcinoids—Are We There Yet?;Journal of Thoracic Oncology;2023-03